Literature DB >> 1627427

Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group.

M Blichert-Toft1, C Rose, J A Andersen, M Overgaard, C K Axelsson, K W Andersen, H T Mouridsen.   

Abstract

The Danish Breast Cancer Cooperative Group (DBCG) conducted a randomized trial comparing breast conservation with mastectomy in patients with invasive mammary carcinoma. From January 1983 to March 1989, the trial accrued a total of 1153 women. Of this number, 905 patients (79%) were randomly assigned to one of the two treatment options, whereas 248 patients (21%) did not accept randomization. Of the randomly assigned patients, 90% received the surgical option to which they had been originally assigned. In the breast conservation arm the tumor was excised with the intention of obtaining free margins determined at gross examination, and radiotherapy was subsequently administered to residual breast tissue. The axilla was dissected in all instances. Patient and tumor characteristics were similar in the two randomization arms. The median follow-up time was 40 months. At 6 years of life-table analysis the probability of recurrence-free survival was 70% in the breast conservation arm against 66% in the mastectomy arm. Survival figures were 79% against 82%, respectively.

Entities:  

Mesh:

Year:  1992        PMID: 1627427

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  77 in total

1.  Triple-negative breast cancer is not a contraindication for breast conservation.

Authors:  Farrell C Adkins; Ana Maria Gonzalez-Angulo; Xiudong Lei; Leonel F Hernandez-Aya; Elizabeth A Mittendorf; Jennifer K Litton; Jamie Wagner; Kelly K Hunt; Wendy A Woodward; Funda Meric-Bernstam
Journal:  Ann Surg Oncol       Date:  2011-09-27       Impact factor: 5.344

2.  Quantitative ultrasonic evaluation of radiation-induced late tissue toxicity: pilot study of breast cancer radiotherapy.

Authors:  Tian Liu; Jun Zhou; Emi J Yoshida; Shermian A Woodhouse; Peter B Schiff; Tony J C Wang; Zheng Feng Lu; Eliza Pile-Spellman; Pengpeng Zhang; Gerald J Kutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-19       Impact factor: 7.038

3.  Commentary--surgical decisions after breast cancer: can patients be too involved in decision making?

Authors:  Nananda F Col; Christine Duffy; Carol Landau
Journal:  Health Serv Res       Date:  2005-06       Impact factor: 3.402

Review 4.  New trends in breast cancer management: is the era of immediate breast reconstruction changing?

Authors:  Bohdan Pomahac; Abram Recht; James W May; Charles A Hergrueter; Sumner A Slavin
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

Review 5.  Radiation therapy after breast-conserving surgery.

Authors:  Naoyuki Shigematsu; Atsuya Takeda; Naoko Sanuki; Junichi Fukada; Takashi Uno; Hisao Ito; Osamu Kawaguchi; Etsuo Kunieda; Atsushi Kubo
Journal:  Radiat Med       Date:  2006-06

6.  Appropriate treatment receipt after breast-conserving surgery.

Authors:  K Guidolin; M Lock; K Vogt; J A McClure; J Winick-Ng; C Vinden; M Brackstone
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

7.  Trends in breast-conserving surgery in Denmark, 1982-2002.

Authors:  Thomas P Ahern; Heidi Larsson; Jens Peter Garne; Deirdre P Cronin-Fenton; Henrik Toft Sørensen; Timothy L Lash
Journal:  Eur J Epidemiol       Date:  2007-11-07       Impact factor: 8.082

8.  Breast-conserving surgery for breast cancer: patterns of care in a geographic region and estimation of potential applicability.

Authors:  R S Foster; M E Farwell; M C Costanza
Journal:  Ann Surg Oncol       Date:  1995-05       Impact factor: 5.344

9.  Breast-conserving surgery in Hong Kong Chinese women.

Authors:  Dacita Suen; Lorraine Chow; Ava Kwong
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

Review 10.  Recent advances in the surgical care of breast cancer patients.

Authors:  Alessandra Mascaro; Massimo Farina; Raffaella Gigli; Carlo E Vitelli; Lucio Fortunato
Journal:  World J Surg Oncol       Date:  2010-01-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.